Skip to main content
. 2020 Jan 28;9(6):2096–2105. doi: 10.1002/cam4.2886

Table 3.

Risk model of thrombosis in patients with JAK2V617F‐mutated MPN

  Multivariate analysis  
HR 95%CI P
Age ≥60 1.76 1.214,2.552 0.003** 1 point
At least one CV 1.559 1.061,2.291 0.024* 1 point
HCT ≥48% 1.635 1.073,2.492 0.022* 1 point
History of thrombosis 2.313 1.573,3.401 <0.0001*** 1 points
V617F% ≥50% 1.804 1.221,2.665 0.003** 1 points

low‐risk (0 points), intermediate‐risk (1 points) and high‐risk(≥2 points).